Overview

A Study in People With Normal Kidney Function and People With Reduced Kidney Function to Test How BI 764198 is Processed in the Body

Status:
Completed
Trial end date:
2020-11-17
Target enrollment:
Participant gender:
Summary
The main objective of this trial is to investigate the influence of moderate and severe renal impairment on the pharmacokinetics of a single dose of BI 764198 in comparison to a group of matched controls with normal renal function.
Phase:
Phase 1
Details
Lead Sponsor:
Boehringer Ingelheim